While extended adjuvant tamoxifen therapy has been found to improve breast cancer-free survival rates in premenopausal women with estrogen-receptor positive breast cancer, new research suggests that may not be without risk…
The Colorado Center for Gynecologic Oncology is excited to share our August Newsletter providing patients with new information, upcoming events and inspiring stories.
It is a strange notion that it can take one moment to shift one’s perspective. We spend a lot of time studying what is wrong in the world around us. We ask why me? Why is this happening? Perhaps another potential question to ask is…why not me?
Vaccination against the human papillomavirus (HPV) is highly protective against precancerous cervical lesions in adolescents and young women compared with placebo, especially those who are negative for HPV at the time of vaccination, a systematic Cochrane review concludes.
Women with endometriosis are at an increased risk of developing ovarian cancer, but not cervical cancer or other cancers affecting the female reproductive organs, a nationwide Finnish study suggests.
The U.S. Food and Drug Administration today approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance of infection as suggested by febrile neutropenia (fever, often with other signs of infection, associated with an abnormally low number of infection-fighting white blood cells), in patients with non-myeloid (non-bone marrow) cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.
The Colorado Center for Gynecologic Oncology is excited to share our July Newsletter providing patients with new information, upcoming events and inspiring stories. This month’s Feature Article, “44 Ways to Make the Day of Someone with Cancer” was written by Dr. Elana Miller, physician and cancer survivor. Based on her personal experience, she has compiled…
Make your friend’s life easier by anticipating his or her needs and giving tangible, much-needed support. Here is a list of the top favors people did for me that made my day (and made my life much easier!) after my cancer diagnosis – Elana Miller, MD.
Clinicians in the not-too-distant future may have something new to offer women with breast cancer and ovarian cancer in whom initial therapy fails to yield a response.
The LA Times reports, compared to women of normal weight, those with obesity are 24% more likely to develop one of a handful of cancers linked to the condition, and their chances of developing cancers of the kidney or endometrium were around twice as high as those of normal-weight women, new research has found.